| Literature DB >> 23311699 |
Erick Prado de Oliveira1, Fernando Moreto, Liciana Vaz de Arruda Silveira, Roberto Carlos Burini.
Abstract
BACKGROUND: High plasma uric acid (UA) is a prerequisite for gout and is also associated with the metabolic syndrome and its components and consequently risk factors for cardiovascular diseases. Hence, the management of UA serum concentrations would be essential for the treatment and/or prevention of human diseases and, to that end, it is necessary to know what the main factors that control the uricemia increase. The aim of this study was to evaluate the main factors associated with higher uricemia values analyzing diet, body composition and biochemical markers.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23311699 PMCID: PMC3573899 DOI: 10.1186/1475-2891-12-11
Source DB: PubMed Journal: Nutr J ISSN: 1475-2891 Impact factor: 3.271
Demographic, anthropometric, clinical and laboratory characterization of individuals according to the uric acid quartile
| 53,4 ± 9.7a | 52.7 ± 9.8a | 51.7 ± 9.5a | 54.1 ± 9.4a | ||
| 69.3 ± 13.3a | 71.5 ± 12.7a | 76.8 ± 16b | 81.6 ± 17c | ||
| 1.62 ± 0.08a | 1.61 ± 0.08a | 1.62 ± 0.1a | 1.63 ± 0.08a | ||
| 26.17 ± 3.7a | 27.2 ± 3.9a | 29.0 ± 5.2b | 30.5 ± 5.2c | ||
| 87.64 ± 11.9a | 90.9 ± 11.1b | 94.2 ± 13c | 99.4 ± 13.7d | ||
| 27.8 ± 5.6a | 29.3 ± 7.8ab | 31 ± 8.4b | 33.6 ± 8.5c | ||
| 10.8 ± 4.1a | 8.8 ± 4b | 8.7 ± 3.9b | 8.8 ± 4b | ||
| 1612 ± 608a | 1584 ± 603a | 1651 ± 700a | 1581 ± 613a | ||
| 51.05 ± 9.7a | 51.7 ± 10.8a | 50.8 ± 9.1a | 51 ± 10.7a | ||
| 18.8 ± 6.11a | 19.1 ± 6.2a | 19.3 ± 6.2a | 18.4 ± 5.9a | ||
| 30.17 ± 8.9a | 29.2 ± 9.2a | 30.0 ± 8.1a | 30.4 ± 8.5a | ||
| 8.12 ± 4.1a | 7.7 ± 3.6a | 8.4 ± 4.1a | 7.9 ± 3.6a | ||
| 8.32 ± 2.95a | 9.0 ± 4.3a | 8.9 ± 3.5a | 9.1 ± 3.5a | ||
| 5.65 ± 2.8a | 6.2 ± 2.8a | 6.1 ± 3.3a | 7.4 ± 3.6b | ||
| 14.1 ± 7.1a | 13.8 ± 8.6a | 13.3 ± 7.6a | 13.1 ± 8.1a | ||
| 183 ± 120.8a | 188 ± 126a | 198 ± 124a | 185 ± 135a | ||
| 3.35 ± 1.8a | 3.5 ± 1.6a | 3.4 ± 1.8a | 3.4 ± 1.5a | ||
| 3 ± 2.73a | 2.8 ± 3.1a | 2.7 ± 3.2a | 2.8 ± 3.0a | ||
| 3.6 ± 2.8a | 2.9 ± 2.5ab | 2.2 ± 2b | 3.1 ± 3.1a | ||
| 1.2 ± 1.7a | 1.1 ± 1.1a | 1.1 ± 1.5a | 1.3 ± 1.8a | ||
| 1.7 ± 1.7a | 1.4 ± 1.2a | 1.5 ± 1.2a | 1.5 ± 1.3a | ||
| 2.13 ± 1.6a | 2.3 ± 1.6a | 2.1 ± 1.5a | 1.9 ± 1.5a | ||
| 1.67 ± 1.6a | 1.7 ± 1.7a | 2.0 ± 1.9a | 1.5 ± 2.2a | ||
| 2.4 ± 2.4a | 2.4 ± 2.5a | 2.4 ± 1.9a | 2.7 ± 2.2a | ||
| 14.27 ± 4.2a | 13.3 ± 3.5a | 13.1 ± 3.6a | 13.5 ± 4a | ||
| 86.4 ± 13a | 83.2 ± 12.5a | 82.3 ± 14.3a | 81.8 ± 15a | ||
| 30.5 ± 8.5a | 32 ± 10.6ab | 32.2 ± 10.2ab | 34.8 ± 14.4b | ||
| 0.89 ± 0.2a | 0.93 ± 0.2ab | 0.96 ± 0.19b | 1.04 ± 0.3c | ||
| 60.2 ± 18a | 52.3 ± 15.5b | 49.3 ± 14.3b | 49.4 ± 13.9b | ||
| 123 ± 35.2a | 132 ± 36.1ab | 134 ± 37.4b | 134 ± 38b | ||
| 101 ± 28a | 102 ± 37a | 100 ± 32a | 104 ± 30a | ||
| 208 ± 41a | 213 ± 44ab | 215 ± 40ab | 220 ± 41b | ||
| 114 (81–171)a | 117 (88–174)ab | 138 (93–183)bc | 177 (124–232)c | ||
| 7.08 ± 0.5a | 7.36 ± 0.6b | 7.5 ± 0.6b | 7.52 ± 0.6b | ||
| 4.51 ± 0.48a | 4.4 ± 0.5a | 4.4 ± 0.5a | 4.4 + 0.5a | ||
| 25 (18–32.5)a | 27 (19–57)ab | 29 (21–44)ab | 34 (25.5-51.5)b | ||
| 8.8 ± 0.4a | 8.9 ± 0.9a | 9.1 ± 0.4a | 9.1 ± 0.4a | ||
| 0.14 (0–0.3)a | 0.2 (0.1-0.75)a | 0.26 (0.1-0.5)a | 0.3 (0.18-0.6)a | ||
| 126 ± 17a | 126 ± 18ab | 132 ± 17b | 130 ± 17ab | ||
| 80 ± 11a | 79 ± 11a | 82 ± 10a | 83 ± 11a |
Different letters = P < 0.05; a,b,c= Anova one-way.
Odds ratio to present the UA at the higher quartile (UA ♂ > 6.5 mg/dL and ♀ UA > 5 mg/dL) according to body composition
| 2.23 (1.32-3.75)* | 2.81 (1.5-5.28)* | 1.97 (1.41-3.41)* | 2.28(1.13-4.6)* | ||
| 8.11 (4.52-14.58)* | 17.51 (7.98-38.48)* | 7.16 (3.6-14.29)* | 13.4 (5.21-34.56)* | ||
| 2.21 (1.39-3.52)* | - | 1.91 (1.15-3.16)* | 1.14 (0.6-2.17) | ||
| 1.96 (1.22-3.16)* | 1.8 (1.03-3.16)* | 1.76 (1.04-2.98)* | 1.54 (0.81-2.9) |
Model 1 – Adjusted for gender, age and other components of body composition analyzed.
Model 2 – Model 1 + Metabolic Syndrome.
Model 3 – Model 1 + c-Reactive Protein, gamma-gt, LDL-c, creatinine, urea and albumin.
Model 4 – Model 3 + HDL-c, triglycerides, hypertension and glucose.
*p < 0.05.
Odds ratio to present the UA at the higher quartile (UA ♂ > 6.5 mg/dL and ♀ UA > 5 mg/dL) according to dietary intake
| 3.22 (1.01-10.27)* | 1.38 (0.22-8.73) | 1.43 (0.23-9.0) | |
| 0.99 (0.45-2.18) | 1.05 (0.36-3.05) | 0.83 (0.28-2.45) | |
| 1.57 (0.62-4.02) | 1.02 (0.27-3.86) | 0.88 (0.23-3.36) | |
| 0.77 (0.35-1.70) | 0.32 (0.10-1.0) | 0.34 (0.11-1.06) | |
| 1.38 (0.64-2.98) | 2.51 (0.71-8.89) | 2.02 (0.56-7.34) | |
| 1.87 (0.82-4.29) | 2.05 (0.62-6.82) | 2.51 (0.75-8.39) | |
| 1.51 (0.61-3.76) | 1.99 (0.33-11.95) | 1.25 (0.20-7.83) | |
| 1.06 (0.44-2.55) | 1.99 (0.45-8.77) | 1.51 (0.33-6.85) |
Model 1 – adjusted for gender, age, Body Mass Index, Total Energy Intake and other components of diet (macronutrient) analyzed.
Model 2 – Model 1 + glucose.
Model 3 – Model 1 + triglycerides.
*p < 0,05.
Odds ratio to present the UA at the higher quartile (UA ♂ > 6.5 mg/dL and ♀ UA > 5 mg/dL) according to biochemical data
| 3.25 (1.09-9.69)* | 1.99 (0.47-8.37) | 0.83 (0.12-5.69) | 0.83 (0.12-5.67) | |
| 1.25 (0.84-1.86) | 1.35 (0.75-2.41) | 2.72 (1.27-5.83)* | 2.53 (1.19-5.41)* | |
| 1.4 (0.9-2.21) | 0.74 (0.38-1.42) | 1.05 (0.41-2.72) | 1.11 (0.43-2.87) | |
| 1.57 (1.12-2.17)* | 1.21 (0.77-1.90) | 0.98 (0.53-1.81) | 1.17 (0.66-2.08) | |
| 4.58 (2.22-9.44)* | 3.41 (1.08-10.7)* | 3.53 (0.91-13.61) | 3.33 (0.87-12.73) | |
| 1.05 (0.76-1.44) | 1.01 (0.64-1.57) | 1.03 (0.56-1.87) | 1.27 (0.74-2.18) | |
| 1.4 (1.04-1.88)* | 1.52 (1.02-2.28)* | 1.16 (0.71-1.90) | 1.15 (0.70-1.89) | |
| 2.37 (1.43-3.91)* | 1.81 (0.91-3.58) | 2.87 (1.10-7.45)* | 2.77 (1.07-7.21)* | |
| 1.83 (1.34-2.50)* | 2.44 (1.59-3.83)* | 2.29 (1.21-4.30)* | 2.76 (1.55-4.90)* |
Model 1 – adjusted for gender, age and other biochemical components analyzed.
Model 2 – Model 1 + Body Mass Index, Muscle Mass Index, waist circumference and% body fat.
Model 3 – Model 2 + Metabolic Syndrome and glomerular filtration rate.
Model 4 – Model 2 + Hypertension and glomerular filtration rate.
*p < 0,05.
Analysis of backward stepwise multiple regression of variables according to UA concentrations
| | Betaβ | EP | B | EP | t | p | | Betaβ | EP | B | EP | t | p |
| | | −0.638 | 0.713 | −0.894 | 0.372 | | | 1.709 | 0.783 | 2.183 | 0.031 | ||
| 0.475 | 0.057 | 0.051 | 0.006 | 8.303 | 0.000 | 0.526 | 0.081 | 0.189 | 0.029 | 6.538 | 0.000 | ||
| −0.393 | 0.057 | −0.040 | 0.006 | −6.925 | 0.000 | −0.415 | 0.081 | −0.041 | 0.008 | −5.152 | 0.000 | ||
| 0.242 | 0.047 | 2.244 | 0.440 | 5.100 | 0.000 | | | | | | | | |
| −0.197 | 0.049 | −0.016 | 0.004 | −4.046 | 0.000 | | | | | | | | |
| 0.36 | 0.00 | 0.28 | 0.00 | ||||||||||